Company Overview and News

0
Jio tops 4G download speed; Idea in upload rate for May 2018

3h moneycontrol
Reliance Jio has topped the chart of fastest 4G telecom operators with an average peak download speed of 22.3 mbps on its network while Idea Cellular registered highest upload speed in May, according to a Trai report.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

5
Sensex falls 218 pts, Nifty below 11k as WPI inflation races to 4-yr high

2018-07-16 freepressjournal.in
Mumbai: The benchmark BSE Sensex dropped by around 218 points or 0.60 per cent due to sell-off in banking, pharma, and metal stocks as investors turned cautious after wholesale inflation surged to a four-year high. The broad-based Nifty cracked below the 11,000-mark as 35 of its constituents closed in the red, led by Dr Reddy’s, Tata Steel and Lupin.
IBN HINDUNILVR BHRQY 533278 VEDL 532454 ICICIBANK 500470 TTST TATASTEEL TATLY HDB 532174 500180 500696 HDFCBANK 500570 BHARTIARTL TATAMOTORS CLNDY COALINDIA TTM

0
Bharti Airtel Limited - AGM/Book Closure

2018-07-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532454 BHRQY BHARTIARTL

0
Bharti Airtel Limited - Shareholders meeting

2018-07-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532454 BHRQY BHARTIARTL

1
Sensex slips from record on profit-booking

2018-07-13 freepressjournal.in
Mumbai: The BSE Sensex retreated from record high to end flat at 36,541.63 today in volatile trade as investors booked profit in recent gainers despite firm global cues.
BAJAJ-AUTO 500325 RELIANCE 532977 BHRQY 533278 532215 500470 AXISBANK RIGD HDFCBANK HEROMOTOCO BHARTIARTL CLNDY RLNIY YESBANK AXB IBN 532648 YYBKY AXBKY 500182 532454 AXBA ICICIBANK TTST TATASTEEL TATLY HDB 532174 500180 HRTQY COALINDIA

0
Idea Cellular slips nearly 3% after Credit Suisse maintains Underperform, sees 17% downside

2018-07-13 moneycontrol
Idea Cellular share price fell 2.7 percent intraday on Friday after global research firm Credit Suisse maintained its Underperform rating on the stock with a target price at Rs 45, implying a 17 percent downside.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

0
Bharti Airtel Limited - Press Release

2018-07-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532454 BHRQY BHARTIARTL

0
Airtel Payments Bank set to acquire new customers after getting nod from RBI, UIDAI

2018-07-12 freepressjournal.in
New Delhi: After running into rough weather due to Aadhaar-related e-KYC issues, Airtel Payments Bank on Thursday said it has received requisite approvals from the Reserve Bank of India and UIDAI to start acquiring new customers.
532454 BHRQY BHARTIARTL

0
Idea-Vodafone merger important for stabilisation of sector, says Govt

2018-07-11 moneycontrol
The telecom sector will stabilise once the Idea Cellular and Vodafone India merger is completed after the two firms fulfil certain 'pending formalities', the government said today.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

0
Bharti Airtel Limited - Updates

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532454 BHRQY BHARTIARTL

0
Idea-Vodafone merger approved, some formalities pending, says Manoj Sinha

2018-07-11 moneycontrol
Telecom Minister Manoj Sinha said today that the government has approved the Idea Cellular and Vodafone India merger, the sector's biggest, but the companies need to complete some formalities for the final closure of the deal.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

0
NCLT nod for merger of Airtel, Bharti Digital Networks

2018-07-10 moneycontrol
Bharti Airtel today said the National Company Law Tribunal (NCLT) has cleared a scheme of arrangement between the company and Bharti Digital Networks, previously known as Tikona Digital Networks. The scheme is now awaiting the approval of the Telecom Department.
532454 BHRQY BHARTIARTL

1
Vodafone optimistic Idea merger will be completed by October, says CEO Vittorio Colao

2018-07-10 livemint
New Delhi: Vodafone Group Plc chief executive officer (CEO) Vittorio Colao has said on Tuesday that he is optimistic that the merger with Idea Cellular Ltd will be completed during his tenure.
532454 VOD VOD VODPF IDEA ICLQY 532822 BHRQY BHARTIARTL

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

15h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

17h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...